Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsDifferential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer ModelBlocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell ProliferationInhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppressionMonoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1Tumor metabolism, cancer cell transporters, and microenvironmental resistance.Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cellsExposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitroMolecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis.Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastasesBerberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer.Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss.Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.Oncolytic viral therapy: targeting cancer stem cellsPriming cancer cells for drug resistance: role of the fibroblast niche.Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture.Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.Immunochemiluminescent detection of galectin-3 in tumoral tissue from prostate.Micro-RNA149 Confers Taxane Resistance to Malignant Mesothelioma Cells via Regulation of P-glycoprotein Expression.Study of the properties of doxorubicin-resistant cells affected by acute leucosis.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine-19 MRI cell tracking.Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging.Roles of Extracellular Vesicles in Metastatic Breast Cancer.Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic DiseasesSulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cellsNakai Has Synergetic Effects on Doxorubicin-Induced Apoptosis
P2860
Q26745710-494B73C4-82DB-4398-AC99-C7CD4A587BE0Q26822987-8A3075C8-0B41-4E20-AF69-E8FB63F753EDQ28547327-2BF7944E-0F59-4208-A945-DCC268DDC053Q33584148-E5521FBF-7474-465C-B1B2-285573FB0A0FQ33688434-68F32C38-E635-4D1F-B3E7-A7F810170B68Q34118737-4681F2F8-5AF1-4988-B120-7A8CA696B847Q34486691-18D99B9F-A7E1-4289-9056-26205E0A843AQ34513382-2BD2695C-C5FE-4F82-8EBB-CA02F2007498Q34956648-3944D331-5EEC-443E-8E78-891665B583B5Q35208091-DE309BCA-EDBF-4750-95EB-BDDEB66C8298Q35870622-128E2462-E747-4C54-A429-1F9CB9EDACF8Q36044905-0D273D61-1596-4F79-A18D-79D9107335CEQ36110948-0E011BBA-CFB4-422D-B38B-7687828F831FQ36391073-45CCEAAE-805D-430E-8FF4-0174B59C42E4Q36531794-E4C18569-9BA0-43B0-89D4-5FF8FD2496C9Q36747524-708F3BD4-0330-4D9F-A399-F38D58BBA250Q37211816-C6AB52A2-CC0A-42A9-A608-BF8649A001D6Q37589832-42DDD4DB-A6C2-4B06-9D6F-9B5F91C3E18FQ37625534-BDF51E9F-1271-4A4C-9C66-3566E66FB43CQ37702718-54582D33-6B6A-430C-B828-5972EBF066F2Q38212255-44CD00ED-426A-46A4-9D2C-CAFA1DA1C793Q38232067-DD487712-CF9F-46E6-8713-8D031A0AEE81Q38289271-5D129E8B-C2CB-42C4-981B-CCC456EE4956Q38952569-A264F8A2-E6CB-4DC0-BA60-FB8ABB2CDF9EQ38968381-AB556E10-7C21-4EA5-9FDC-681F294ADB18Q39302599-F9B1DB46-2A10-4792-AF18-740A781A0D66Q41493235-6B00909E-447D-40A9-A73B-5535E0B7487EQ42580165-B7BD0604-8957-432D-8077-F766ED9663CAQ47271729-F09A72CB-3704-411B-8FE7-961DF2F73180Q47278974-EE5A7CAA-74F0-4DD0-A54E-03AAAA93ACD4Q48308048-A98A0BCC-8600-42F0-8391-CD6F558BE048Q48507775-D13E33C9-817E-470A-94BF-F970F2ED1FE9Q51581869-F4837D94-65A5-4DF1-A117-6017E16C142EQ55035055-C998E226-27CB-4C6E-A6A4-53BC103850F5Q57167169-172556CF-6A78-4C11-B20C-57967D5067D7Q58765247-8569F3DF-A37E-41C2-8899-D9EC9B53D568Q58805802-F97CD73D-5FDE-4FA5-9124-05028258CDC2
P2860
Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased expression of P-glyc ...... static 4T1 breast cancer model
@ast
Increased expression of P-glyc ...... static 4T1 breast cancer model
@en
Increased expression of P-glyc ...... static 4T1 breast cancer model
@nl
type
label
Increased expression of P-glyc ...... static 4T1 breast cancer model
@ast
Increased expression of P-glyc ...... static 4T1 breast cancer model
@en
Increased expression of P-glyc ...... static 4T1 breast cancer model
@nl
prefLabel
Increased expression of P-glyc ...... static 4T1 breast cancer model
@ast
Increased expression of P-glyc ...... static 4T1 breast cancer model
@en
Increased expression of P-glyc ...... static 4T1 breast cancer model
@nl
P2093
P2860
P1476
Increased expression of P-glyc ...... static 4T1 breast cancer model
@en
P2093
Aliyya Haque
Kamilah Jackson
Krzysztof Moroz
Rachna Jetly
Sidhartha Hazari
Srikanta Dash
P2860
P304
P356
10.1016/J.AJPATH.2010.10.029
P407
P577
2011-02-01T00:00:00Z